George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Regulatory News (IXI)

Share Price Information for Ixico (IXI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.625
Bid: 8.50
Ask: 8.75
Change: 0.00 (0.00%)
Spread: 0.25 (2.941%)
Open: 8.625
High: 8.625
Low: 8.625
Prev. Close: 8.625
IXI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

11 Feb 2020 07:00

RNS Number : 5428C
IXICO plc
11 February 2020
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

IXICO PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

CANACCORD GENUITY GROUP INC

City and country of registered office (if applicable)

VANCOUVER, CANADA

4. Full name of shareholder(s) (if different from 3.)v

Name

DISCRETIONARY CLIENTS

City and country of registered office (if applicable)

As above

5. Date on which the threshold was crossed or reachedvi:

07 FEBRUARY 2020

6. Date on which issuer notified (DD/MM/YYYY):

10 FEBRUARY 2020

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

10.9998

10.9998

47,091,292

Position of previous notification (if

applicable)

11.2463

11.2463

 

 

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00BFXR4C20

5,179,957

10.9998

SUBTOTAL 8. A

5,179,957

10.9998

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

 

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

 

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

 

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

Canaccord Genuity Group Inc.

10.9998

10.9998

 

Canaccord Genuity Wealth Group Holdings Limited

10.9998

10.9998

 

Canaccord Genuity Wealth Group Holdings (Jersey) Limited

10.9998

10.9998

 

Canaccord Genuity Wealth Group Limited

10.9998

10.9998

 

Canaccord Genuity Wealth Limited

3.2489

3.2489

 

Hargreave Hale Ltd

7.7509

7.7509

 

 

10. In case of proxy voting, please identify:

 

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

 

11. Additional informationxvi

 

 

 

Place of completion

BLACKPOOL, ENGLAND

Date of completion

10 FEBRUARY 2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLTMMRTMTMBBFM
Date   Source Headline
16th Jan 20172:00 pmRNSAnnual Report and Accounts and Notice of AGM
13th Jan 20173:25 pmRNSHolding(s) in Company
12th Jan 20172:56 pmRNSHolding(s) in Company
4th Jan 20173:43 pmRNSIssue of 590,093 Deferred Consideration Shares
23rd Dec 20167:00 amRNSBuyback and Cancellation of Deferred Shares
20th Dec 20167:00 amRNSFull Year Results
16th Nov 20167:00 amRNSParticipation in major EU partnership (ROADMAP)
21st Oct 20167:00 amRNSPre-Close Trading Update
20th Oct 20167:00 amRNS$1.2m contract with new global pharma customer
19th Oct 20167:00 amRNSIXICO presents at CAMD regulatory workshop
10th Oct 20167:00 amRNSEUR1m funding as a partner in major EU consortium
3rd Oct 20167:00 amRNSAppointment of Shore Capital as Nominated Adviser
3rd Oct 20167:00 amRNSAppointment of Shore Capital
26th Sep 20165:14 pmRNSDirector/PDMR Shareholding
26th Sep 20161:58 pmRNSExercise of Share Options
16th Sep 20167:00 amRNSBoard changes
13th Sep 20167:00 amRNSPresentation of Assessa® PML at ECTRIMS
29th Jul 201610:25 amRNSWeb-Based Technology Improves Paediatric ADHD Care
7th Jun 20167:00 amRNSHalf Yearly Report to 31 March 2016
2nd Jun 20167:00 amRNSCygnus joins Dementias Platform UK
4th Apr 20167:00 amRNSConsortium and Five Year Contract
31st Mar 20167:00 amRNSReal world study of Digital Biomarkers
31st Mar 20167:00 amRNSGrant of Awards to Directors
30th Mar 20167:00 amRNSNHS emergency and out-of-hours services contract
9th Mar 20169:30 amRNSEuropean research to tackle dementia
3rd Mar 20167:00 amRNSMehealth® used in American Academy of Pediatrics
1st Mar 201610:35 amRNSDirector/PDMR Shareholding
5th Feb 20167:00 amRNSDirector/PDMR Shareholding
4th Feb 20167:00 amRNSDirector/PDMR Shareholding
29th Jan 201610:45 amRNSResult of AGM
29th Jan 20167:00 amRNSAGM Statement
22nd Jan 20167:00 amRNSSelected for two NHS Innovation Test Beds
21st Jan 20167:00 amRNSMyBrainBook wins Regional Business Award
18th Jan 20167:00 amRNSFour contracts awarded worth over £3.0m
7th Jan 20167:00 amRNSFinancial Results for the year ended 30 Sept 2015
21st Dec 20152:03 pmRNSUpdate on Issued Share Capital
7th Dec 201510:04 amRNSResult of General Meeting
18th Nov 20153:45 pmRNSPublication of Circular
18th Nov 20157:00 amRNSProposed acquisition of Optimal Medicine & placing
2nd Nov 20153:38 pmRNSTotal Voting Rights
19th Oct 20157:00 amRNSPre-Close Trading Update
12th Oct 20151:16 pmRNSAdditional Listing
9th Oct 20157:00 amRNSCollaboration with leading pharmaceutical co in MS
2nd Oct 201511:18 amRNSExercise of Share Options
28th Aug 20157:00 amRNSIXICO awarded significant long-term contract
29th Jun 20157:00 amRNSVirtualScopics Alliance Update
25th Jun 20151:21 pmRNSHolding(s) in Company
26th May 20157:01 amRNSRelease of beta version of MyBrainBook®
12th May 20157:00 amRNSLaunch of UK Government funded project
30th Apr 20157:49 amRNSLaunch of dementia care digital platform

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.